These European Covid-19 infection charts do NOT look good – almost every country in Europe has a higher Covid case level now than before the huge Omicron winter wave of 2021. We compared Covid cases numbers for 27th September 2021 and 27th September 2022 across a few European countries to see how they were faring
Researchers from the University of Oxford have today reported new findings from a Phase 1 clinical trial studying the safety and immune response of an intranasally-administered vaccine against COVID-19.The study was performed at the University in collaboration with AstraZeneca and used the same vaccine based on the ChAdOx1 adenovirus vector, as is already licensed for
A Penn State team conducted the largest study to date on the risk of developing myocarditis, or inflammation of the heart muscle, as a result of having the coronavirus versus experiencing inflammation following COVID-19 vaccination. The risk of developing myocarditis — or inflammation of the heart muscle — is seven times higher with a COVID-19
One of the dreams of cancer therapy is to use the power of the body to heal itself. This dream, long in the making, is becoming a reality thanks to deep and fundamental understandings of the immune system, the primary means by which we protect ourselves from external and internal threats. The immune system recognizes
The XBB variant was first sequenced in India in late August 2022. It is most definitely NOT a “Singapore Variant”. There is some anecdotal evidence that the XBB variant may have been uncovered in the United States in early August 2022, however those sequences have not been uploaded to the global Gisaid database. The current XBB
Three-dimensional bioprinting is an emerging technology that has the potential to build human tissue, on demand, to treat a wide range of human diseases. However, bridging the gap from research at the benchtop to clinical translation requires a host of resources, time, and energy. A new Science Translational Medicine perspective authored by researchers in Carnegie Mellon University’s
A study from the Karolinska Institutet shows that the coronavirus variant BA.2.75.2, a subvariant of omicron, more easily bypasses neutralizing antibodies in the blood and is resistant to several monoclonal antibody treatments. This means an increased risk of sars-cov-2 infection this winter, unless the new updated bivalent vaccines can strengthen the immunity of the population. The results
Groundbreaking trial aims to reverse the paralysis and other abnormal functions of spina bifida before birth Three babies have been born after receiving the world’s first spina bifida treatment combining surgery with stem cells. This was made possible by a landmark clinical trial at UC Davis Health. The one-of-a-kind treatment, delivered while a fetus is
SARS-CoV-2, the COVID-19 virus, caused significant neuron damage and inflammation within a week of infection in rhesus macaque monkeys, according to a new study. The researchers from the California National Primate Research Center at the University of California, Davis, also discovered that aged monkeys with Type 2 diabetes experienced worse virus-induced neurological damage. The findings,
CARTITUDE-1 is a phase 1b–2 study evaluating ciltacabtagene autoleucel (cilta-cel), a chimeric antigen receptor T cell therapy with two B-cell maturation antigen–targeting single-domain antibodies, in patients with relapsed or refractory multiple myeloma. Primary efficacy outcomes have previously been reported. In this paper are reported health-related quality of life (HRQOL) secondary outcomes evaluated using patient-reported outcomes.
